Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether XP12B is effective and safe in the treatment of women with heavy menstrual bleeding associated with menorrhagia.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ferring Pharmaceuticals
NCT06740929 · Heavy Menstrual Bleeding, Bleeding Disorder
NCT05922657 · Heavy Menstrual Bleeding, Abnormal Uterine Bleeding, and more
NCT06634719 · Heavy Menstrual Bleeding
NCT06538454 · Arterial Hypertension, Postmenopausal; Menorrhagia, and more
NCT05538689 · Metrorrhagia, Pelvic Pain, and more
Investigative Site
Tucson, Arizona
Investigative Site
Tucson, Arizona
Investigative Site
Little Rock, Arkansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions